PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10184838

Biocompatibility: the latest developments.

J van Loon·P Mars
View original source ↗Export metadata ↓

Abstract

The standards for biological evaluation of medical devices are currently being evaluated. This article presents the rationale behind the current ISO 10993 series and discusses the work in progress to revise elements of the standards and to incorporate new areas. Particular issues being addressed include a new definition of biocompatibility, and quality of health, which will include product risk assessment and surveillance in the market place.

Explore related subjects

Biocompatible MaterialsEuropeGuidelines as TopicHumansInternational CooperationProduct Surveillance, PostmarketingRisk ManagementTerminology as TopicJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J van Loon, P Mars. 1997. Biocompatibility: the latest developments.. https://pubmed.ncbi.nlm.nih.gov/10184838/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Characterization of a novel calcium phosphate/sulphate bone cement.

Apatitic cements have shown excellent biocompatibility and adequate mechanical properties but have slow resorption in the human body. To assure that new bone tissue grows into the bone defect, a certain porosity is necessary although hard to achieve in injectable cements with suitable mechanical properties. An attempt was made by mixing alpha-tricalcium phosphate (alpha-TCP), calcium sulphate hemihydrate (CSH) and an aqueous solution containing 2.5 wt% of Na(2)HPO(4). The aim was to obtain a material containing two phases: a) one apatitic phase (calcium-deficient hydroxyapatite; CDHA) and b) one resorbable phase (calcium sulphate dihydrate; CSD). alpha-TCP and CSH mixtures were produced at relative intervals of 20 wt%. The liquid-to-powder (L/P) ratio to obtain a paste was 0.32 mLg(-1). The highest compressive strength (34 MPa) was obtained for the pure alpha-TCP sample. The strength was, in a first approximation, directly correlated to the weight proportions of the powders. X-ray diffraction analysis showed that the relative intensity for CDHA increased linearly, and the one for CSD decreased exponentially, when the amount of alpha-TCP increased. Thus, CSH ceased to transform to CSD when the amount of alpha-TCP increased. Observations in environmental scanning electron microscopy confirmed the X-ray diffraction results. CSH-crystals (100 microm) were embedded in the HA-matrix permitting gradual porosity in the material when resorbed.

Biocompatible Materials↗
PubMed2002

Effects of ion concentration and pH on hydroxyapatite deposition from aqueous solution onto titanium by the thermal substrate method.

A new hydrocoating method (the thermal substrate method) has been proposed for coating calcium phosphates, such as hydroxyapatite, onto titanium substrates in an aqueous solution. The influences of several solution properties on the thermal substrate method were examined. The solutions used included 3 mmol dm(-3) Ca(H(2)PO(4))(2) and 7 mmol dm(-3) CaCl(2) as a reference concentration solution. The ion concentration was changed from 0.1 to 2 times with respect to the reference concentration. The experimental studies were conducted under the following conditions: temperature = 140 degrees C, heating time = 10-20 min., pH = 4-8 and Ca/P = 0.0167-16.7. The type of precipitate changed, depending on the pH and ion concentration. In the reference solution with pH > 6, predominantly hydroxyapatite was precipitated onto titanium. By contrast, only CaHPO(4) was formed in the solution of pH 4. In the solution with an ion concentration of one-tenth the reference solution, CaHPO(4) was also precipitated. The addition of H(3)PO(4) to the 0.1-times solution accelerated the precipitation rate of HA. It is suggested that the PO(4) (3-) concentration was insufficient to form HA in the Ca/P = 1.67 solution.

Biocompatible Materials↗
PubMed2002

Interaction of oxidation and crosslinking in gamma-irradiated ultrahigh molecular-weight polyethylene.

The interaction between oxidation and crosslinking in gamma-irradiated ultrahigh molecular-weight polyethylene with and without artificial aging was studied. The effect of the atmosphere during irradiation (air vs. low oxygen) occurred primarily within about 0.5 mm of the surface, that is, the depth to which oxygen had diffused when the polyethylene specimen was machined and when it was irradiated. Irradiation in the presence of oxygen induced oxidation instead of crosslinking, so that the level of crosslinking achieved was lower than that which normally would occur at the same dose in the absence of oxygen. Subsequent artificial aging reduced the gel content (crosslinking) and had a maximal effect on the surface and subsurface regions for the gamma-air and gamma-low oxygen polyethylenes, respectively. Thus the storage environments and durations prior to irradiation and prior to artificial aging must be taken into account when attempting to duplicate the oxidation-crosslinking profiles that occur with actual implants in clinical use. In addition, the oxidation mechanisms initiated by the artificial aging method used in this study (i.e., heating in air to 80 degrees C) initiated somewhat different oxidative reactions from those that occur during prolonged shelf life at room temperature or in vivo. In particular, the formation of a peak of oxidation below the free surface of the polyethylene is due to the combined effects of the distribution of residual free radicals and the diffusion gradient of the oxygen. The interactive relationship between oxidation and crosslinking characterized in the present study provides a fundamental basis for understanding the wear behavior of gamma-sterilized components in past clinical use. It also provides guidelines for the development of polyethylenes with improved resistance to oxidation and wear, with particular relevance to estimation of the amount of crosslinking need- ed to potentially eliminate the clinical problem of osteolysis.

Biocompatible Materials↗